A randomized, multicenter, double-blind, placebo-controlled, parallel group study of the 12-month effect of treatment with once daily investigational nasal spray on the growth velocity of children, 3 to 8 years of age with perennial allergic rhinitis (PAR)

The goal of this study is to evaluate the effects of an investigational nasal spray in children with year-round allergy symptoms (perennial allergic rhinitis). Subjects must be 3 to 8 years old and have perennial allergic rhinitis but be otherwise in good health. The study will include 11 visits and will last approximately one year.

Your child may be eligible to participate in this study if he or she:

• Is 3 to 8 years old
• Has year-round allergies (perennial allergic rhinitis)
• Is in otherwise good health

This is a partial list of eligibility requirements. To inquire about your child's eligibility, please call the contact number provided. If you wish to inquire via e-mail, please include the title of the study in your message.